Clinical Trial Update: A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance

View source ↗

Summary

A completed clinical trial evaluated a tailored polygenic risk score to predict progression in men with prostate cancer on active surveillance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Prostate Cancer | Status: COMPLETED